The earnings call reflects a strong performance in revenue growth, particularly in the Sanara Surgical segment, with significant improvements in gross margins and adjusted EBITDA. However, the company faced challenges such as increased net loss and operating expenses, as well as higher debt obligations and interest expenses. While there are significant positive strides, particularly in product sales and distributor expansion, the financial challenges balance the overall outlook.

Company Guidance -

Q2 2025

During the first quarter of 2025 earnings call, Sanara MedTech reported a net revenue of $23.4 million for its Sanara Surgical team, marking a 26% increase year-over-year. The company's growth was largely driven by a 28% rise in sales of its soft tissue repair products, totaling $20.5 million. Sales of bone fusion products also grew by 18% to $2.9 million. Despite a net loss for the Sanara Surgical Segment that increased by $200,000 to $600,000, adjusted EBITDA rose by $1.5 million to $2.7 million. Gross margins were enhanced, with gross profit increasing by 30% to $21.6 million, and the gross margin improved by approximately 240 basis points to 92% of net revenue. Operating expenses rose by 30% to $23.7 million, primarily due to a 32% increase in selling, general, and administrative expenses. The company also focused on expanding its distributor network, securing agreements with over 400 distributor partners, and increasing penetration in existing healthcare facilities. The Tissue Health Plus segment invested in developing a value-based wound care strategy and prepared to launch its pilot program in the second quarter. As of March 31, 2025, Sanara MedTech held $20.7 million in cash and $42.8 million in principal debt obligations, with $12.25 million of available borrowing capacity.

Sanara Surgical Revenue Growth

Sanara Surgical delivered net revenue of $23.4 million, representing 26% growth year-over-year, driven by a 28% increase in soft tissue repair product sales.

Strong Performance in Product Sales

Sales of CellerateRX Surgical and BIASURGE products fueled performance, and bone fusion products also saw an 18% increase year-over-year.

Enhanced Gross Margins

Gross profit increased by $5 million to $21.6 million, with a gross margin increase of approximately 240 basis points to 92% of net revenue.

Adjusted EBITDA Improvement

Sanara Surgical Segment adjusted EBITDA increased by $1.5 million year-over-year to $2.7 million.

Expansion of Distributor Network

Distributor network expanded to over 400 partners, up from over 250 in Q1 2024, providing increased sales coverage.

Tissue Health Plus Technology Platform Release

The first release of THP's technology platform, including the THP CoPilot app, was announced on May 1st, marking a pivotal milestone in wound care.

Sanara MedTech (SMTI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

SMTI Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 13, 2025	2025 (Q2)	-0.44 / -	-0.41	―	―	―
May 14, 2025	2025 (Q1)	-0.51 / -0.41	-0.21	-95.24% (-0.20)
Mar 25, 2025	2024 (Q4)	-0.12 / -0.18	-0.03	-500.00% (-0.15)	―
Nov 12, 2024	2024 (Q3)	-0.62 / -0.34	-0.13	-161.54% (-0.21)
Aug 12, 2024	2024 (Q2)	-0.21 / -0.41	-0.22	-86.36% (-0.19)
May 13, 2024	2024 (Q1)	-0.07 / -0.21	-0.14	-50.00% (-0.07)
Mar 25, 2024	2023 (Q4)	-0.13 / -0.03	-0.01	-200.00% (-0.02)
Nov 13, 2023	2023 (Q3)	0.00 / -0.13	-0.18	27.78% (+0.05)
Aug 14, 2023	2023 (Q2)	-0.13 / -0.22	-0.42	47.62% (+0.20)
May 15, 2023	2023 (Q1)	-0.33 / -0.14	-0.41	65.85% (+0.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

SMTI Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 14, 2025	$35.10	$31.30	-10.83%
Mar 25, 2025	$35.69	$31.20	-12.58%
Nov 12, 2024	$34.60	$37.22	+7.57%
Aug 12, 2024	$27.83	$32.04	+15.13%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sanara MedTech (SMTI) report earnings?

Sanara MedTech (SMTI) is schdueled to report earning on Aug 13, 2025, Before Open (Confirmed).

What is Sanara MedTech (SMTI) earnings time?

Sanara MedTech (SMTI) earnings time is at Aug 13, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is SMTI EPS forecast?

SMTI EPS forecast for the fiscal quarter 2025 (Q2) is -0.44.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing